Borregaard ASA (LON:0QB7)

Market Cap	1.17B -2.2%
Revenue (ttm)	597.34M +0.1%
Net Income	42.84M -37.0%
EPS	0.43 -37.0%
Shares Out	n/a
PE Ratio	27.41
Forward PE	15.81
Dividend	0.37 (0.25%)
Ex-Dividend Date	Apr 17, 2026

Volume	10,180
Average Volume	10,592
Open	145.20
Previous Close	146.58
Day's Range	145.40 - 146.40
52-Week Range	142.60 - 211.50
Beta	0.59
RSI	20.75
Earnings Date	Apr 29, 2026

About Borregaard ASA

Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry. Its BioMaterials segment develops, ...

• Industry: Chemicals and Allied Products
• Founded: 2012
• Employees: 1,193
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QB7

Financial Performance

In 2025, Borregaard ASA's revenue was 7.71 billion, an increase of 1.26% compared to the previous year's 7.62 billion. Earnings were 620.00 million, a decrease of -24.67%.

Financial numbers in NOK